THRM
INFU

Hundzinski Ronald T

Known title: DirectorCIK: 0001488024

Hundzinski Ronald T's purchase track record

Hundzinski Ronald T has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
5/19/2025INFU$30K+55.7%+52.3%
5/8/2025THRM$133K+24.4%+35.2%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Gentherm Announces Q3 2026 Release Date and Special Dividend. Gentherm has scheduled the date for its 2026 third‑quarter news release and the accompanying conference call. The company also announced a special dividend and made changes to its board of directors, which could reflect a shift in strategic focus. Both items were disclosed in recent filings and press releases.

this person other insiders at THRM

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

INFU Shares Business Overview, Emphasizes Patient-First Strategy. INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.

this person other insiders at INFU

Transaction History

THRM▲ Buy$0
INFU▲ Buy$30K
THRM▲ Buy$133K
THRM▲ Buy$0
THRM▲ Buy$0
THRM▲ Buy$0
THRM▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.